Gilead Sciences, Inc.
GILD
$148.95
$5.183.60%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 22.43% | 143.58% | 21.44% | 131.53% | 24.77% |
| Total Depreciation and Amortization | -0.87% | -0.58% | -0.43% | 0.87% | 0.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6,531.25% | -61.31% | -66.25% | -87.35% | -97.31% |
| Change in Net Operating Assets | -225.05% | -146.26% | -30.27% | -125.05% | 188.95% |
| Cash from Operations | 11.83% | -4.66% | -37.58% | -20.82% | 37.16% |
| Capital Expenditure | -39.46% | -4.26% | 17.69% | 0.95% | 31.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -712.00% | 70.70% | 86.18% | 93.25% | 73.12% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -33,933.33% | -11,400.00% | -7,852.00% | -101.96% | 98.71% |
| Cash from Investing | -715.56% | 39.86% | -589.25% | 81.20% | 69.05% |
| Total Debt Issued | -- | -- | -- | -- | 346,300.00% |
| Total Debt Repaid | -14.29% | 91.96% | 99.51% | -- | -- |
| Issuance of Common Stock | -81.50% | -1.02% | 440.00% | 72.60% | 565.38% |
| Repurchase of Common Stock | 34.29% | -45.00% | -427.00% | -82.50% | -133.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.16% | -2.24% | -2.26% | -2.02% | -3.18% |
| Other Financing Activities | -34.04% | -67.07% | -82.86% | -50.43% | -42.42% |
| Cash from Financing | -155.88% | -7.98% | 46.94% | -151.73% | 305.64% |
| Foreign Exchange rate Adjustments | 109.09% | -111.36% | 763.64% | 205.56% | -248.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -95.28% | -3.45% | -42.96% | -51.06% | 1,203.95% |